Patents by Inventor Ronald Freudenberger

Ronald Freudenberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Oxypurinol as an Inhibitor of Anti-Neoplastic Agent-Induced Cardiotoxicity
    Publication number: 20080039408
    Abstract: The disclosure relates to methods of ameliorating or preventing cardiotoxicity caused by anti-neoplastic agents, such as doxorubicin, by administering to a patient oxypurinol, salt or derivatives thereof, before, during or after administration of the anti-neoplastic agent.
    Type: Application
    Filed: December 6, 2005
    Publication date: February 14, 2008
    Inventor: Ronald Freudenberger